Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France

Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
doi: https://doi.org/10.1101/2023.01.11.23284137

Article Information

doi 
https://doi.org/10.1101/2023.01.11.23284137
History 
  • January 12, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Cynthia Tamandjou1,#,*,
  2. Vincent Auvigne1,#,
  3. Justine Schaeffer1,
  4. Sophie Vaux1 and
  5. Isabelle Parent du Châtelet1
  1. 1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, French national public health agency. F-94415 Saint-Maurice, France
  1. ↵*Corresponding author; email: cynthia.tamandjou{at}santepubliquefrance.fr

  1. ↵# These authors contributed equally to this work

Back to top
Posted January 12, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
medRxiv 2023.01.11.23284137; doi: https://doi.org/10.1101/2023.01.11.23284137
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area